Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Prostate Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 61 articles: HTML format

Single Articles

March 2008
1. CLARK J , Attard G, Jhavar S, Flohr P, et al
   Complex patterns of ETS gene alteration arise during cancer development in the human prostate.
   Oncogene. 2008;27:1993-2003.
   PubMed     Related articles    Abstract available
   
   
   
2. DEEP G , Oberlies NH, Kroll DJ, Agarwal R, et al
   Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
   Oncogene. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
3. ASIM M , Siddiqui IA, Hafeez BB, Baniahmad A, et al
   Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.
   Oncogene. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. LIU S , Vinall RL, Tepper C, Shi XB, et al
   Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
   Oncogene. 2008;27:499-505.
   PubMed     Related articles    Abstract available
   
   
   
5. BERENGUER C , Boudouresque F, Dussert C, Daniel L, et al
   Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
   Oncogene. 2008;27:506-18.
   PubMed     Related articles    Abstract available
   
   
   
6. CAI CQ , Peng Y, Buckley MT, Wei J, et al
   Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
   Oncogene. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. TO-HO KW , Cheung HW, Ling MT, Wong YC, et al
   MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
   Oncogene. 2008;27:347-57.
   PubMed     Related articles    Abstract available
   
   
   
8. EL-OMAR EM , Ng MT, Hold GL
   Polymorphisms in Toll-like receptor genes and risk of cancer.
   Oncogene. 2008;27:244-52.
   PubMed     Related articles    Abstract available
   
   
   December 2007
9. OLSHAVSKY NA , Groh EM, Comstock CE, Morey LM, et al
   Cyclin D3 action in androgen receptor regulation and prostate cancer.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
10. MCCRACKEN SR , Ramsay A, Heer R, Mathers ME, et al
    Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. YU S , Wong YC, Wang XH, Ling MT, et al
    Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
12. LEOTOING L , Meunier L, Manin M, Mauduit C, et al
    Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. CANGEMI R , Mensah A, Albertini V, Jain A, et al
    Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. PEAK JC , Jones NP, Hobbs S, Katan M, et al
    Phospholipase Cgamma1 regulates the Rap GEF1-Rap1 signalling axis in the control of human prostate carcinoma cell adhesion.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. BROOKE GN , Parker MG, Bevan CL
    Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. SIDDIQUI IA , Malik A, Adhami VM, Asim M, et al
    Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
17. BEACH S , Tang H, Park S, Dhillon AS, et al
    Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
18. PETROVICS G , Liu A, Shaheduzzaman S, Furusato B, et al
    Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.
    Oncogene. 2007;26:6684.
    PubMed     Related articles   
    
    
    
19. MIGLIACCIO A , Varricchio L, De Falco A, Castoria G, et al
    Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth.
    Oncogene. 2007;26:6619-29.
    PubMed     Related articles    Abstract available
    
    
    
20. SCOTLANDI K , Zuntini M, Manara MC, Sciandra M, et al
    CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity.
    Oncogene. 2007;26:6604-18.
    PubMed     Related articles    Abstract available
    
    
    September 2007
21. OZEN M , Creighton CJ, Ozdemir M, Ittmann M, et al
    Widespread deregulation of microRNA expression in human prostate cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. XIAO W , Zhang Q, Habermacher G, Yang X, et al
    U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. ZISMAN-ROZEN S , Fink D, Ben-Izhak O, Fuchs Y, et al
    Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.
    Oncogene. 2007;26:6093-8.
    PubMed     Related articles    Abstract available
    
    
    
24. YULI C , Shao N, Rao R, Aysola P, et al
    BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
    Oncogene. 2007;26:6031-7.
    PubMed     Related articles    Abstract available
    
    
    August 2007
25. DEMICHELIS F , Fall K, Perner S, Andren O, et al
    TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
    Oncogene. 2007;26:5692.
    PubMed     Related articles   
    
    
    
26. LI ZG , Yang J, Vazquez ES, Rose D, et al
    Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. PULUKURI SM , Patibandla S, Patel J, Estes N, et al
    Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors.
    Oncogene. 2007;26:5229-37.
    PubMed     Related articles    Abstract available
    
    
    July 2007
28. ATTARD G , Clark J, Ambroisine L, Fisher G, et al
    Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. YANG F , Strand DW, Rowley DR
    Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. DURKIN ME , Ullmannova V, Guan M, Popescu NC, et al
    Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth.
    Oncogene. 2007;26:4580-9.
    PubMed     Related articles    Abstract available
    
    
    
31. BEKE L , Nuytten M, Van Eynde A, Beullens M, et al
    The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.
    Oncogene. 2007;26:4590-5.
    PubMed     Related articles    Abstract available
    
    
    June 2007
32. RIGAS AC , Robson CN, Curtin NJ
    Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. YUAN TC , Lin FF, Veeramani S, Chen SJ, et al
    ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. KIKUNO N , Shiina H, Urakami S, Kawamoto K, et al
    Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
35. MAXWELL PJ , Gallagher R, Seaton A, Wilson C, et al
    HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. LEHEN'KYI V , Flourakis M, Skryma R, Prevarskaya N, et al
    TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. ZHANG X , Leung YK, Ho SM
    AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. CRAFT CS , Romero D, Vary CP, Bergan RC, et al
    Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
39. SHEPARD CR , Kassis J, Whaley DL, Kim HG, et al
    PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors.
    Oncogene. 2007;26:3020-6.
    PubMed     Related articles    Abstract available
    
    
    
40. WANG Q , Williamson M, Bott S, Brookman-Amissah N, et al
    Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
41. VAIRA V , Lee CW, Goel HL, Bosari S, et al
    Regulation of survivin expression by IGF-1/mTOR signaling.
    Oncogene. 2007;26:2678-84.
    PubMed     Related articles    Abstract available
    
    
    
42. CLARK J , Merson S, Jhavar S, Flohr P, et al
    Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.
    Oncogene. 2007;26:2667-73.
    PubMed     Related articles    Abstract available
    
    
    
43. WANG Y , Kreisberg JI, Bedolla RG, Mikhailova M, et al
    A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
44. YEMELYANOV A , Czwornog J, Chebotaev D, Karseladze A, et al
    Tumor suppressor activity of glucocorticoid receptor in the prostate.
    Oncogene. 2007;26:1885-96.
    PubMed     Related articles    Abstract available
    
    
    
45. MCCABE NP , De S, Vasanji A, Brainard J, et al
    Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
46. WU D , Zhau HE, Huang WC, Iqbal S, et al
    cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. TAKAYAMA K , Kaneshiro K, Tsutsumi S, Horie-Inoue K, et al
    Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
48. BUSA R , Paronetto MP, Farini D, Pierantozzi E, et al
    The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. DEMICHELIS F , Fall K, Perner S, Andren O, et al
    TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. VIDAL GA , Clark DE, Marrero L, Jones FE, et al
    A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.
    Oncogene. 2007;26:462-6.
    PubMed     Related articles    Abstract available
    
    
    
51. SUN HL , Liu YN, Huang YT, Pan SL, et al
    YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. HWANG SI , Thumar J, Lundgren DH, Rezaul K, et al
    Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues.
    Oncogene. 2007;26:65-76.
    PubMed     Related articles    Abstract available
    
    
    December 2006
53. BLOCH M , Ousingsawat J, Simon R, Schraml P, et al
    KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
54. XU J , Gao M, Fan S, Meng Q, et al
    Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
55. CAVARRETTA IT , Neuwirt H, Untergasser G, Moser PL, et al
    The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
56. KAWANO Y , Kitaoka M, Hamada Y, Walker MM, et al
    Regulation of prostate cell growth and morphogenesis by Dickkopf-3.
    Oncogene. 2006;25:6528-37.
    PubMed     Related articles    Abstract available
    
    
    
57. CROSBY ME , Jacobberger J, Gupta D, Macklis RM, et al
    E2F4 regulates a stable G(2) arrest response to genotoxic stress in prostate carcinoma.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
58. CHEN C , Sun X, Guo P, Dong XY, et al
    Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
59. SUBBARAYAN V , Krieg P, Hsi LC, Kim J, et al
    15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
    Oncogene. 2006;25:6015-25.
    PubMed     Related articles    Abstract available
    
    
    
60. LEE MG , Huh JS, Chung SK, Lee JH, et al
    Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.
    Oncogene. 2006;25:5807-22.
    PubMed     Related articles    Abstract available
    
    
    August 2006
61. PEDUTO L , Reuter VE, Sehara-Fujisawa A, Shaffer DR, et al
    ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression.
    Oncogene. 2006;25:5462-6.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: